Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04382664
Title UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ultimovacs ASA
Age Groups: adult | senior
Covered Countries USA | GBR | BEL

No variant requirements are available.